Cargando…

Functional Relevance of Improbable Antibody Mutations for HIV Broadly Neutralizing Antibody Development

HIV-1 broadly neutralizing antibodies (bnAbs) require high levels of activation-induced cytidine deaminase (AID)-catalyzed somatic mutations for optimal neutralization potency. Probable mutations occur at sites of frequent AID activity, while improbable mutations occur where AID activity is infreque...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wiehe, Kevin, Bradley, Todd, Meyerhoff, R. Ryan, Hart, Connor, Williams, Wilton B., Easterhoff, David, Faison, William J., Kepler, Thomas B., Saunders, Kevin O., Alam, S. Munir, Bonsignori, Mattia, Haynes, Barton F.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Cell Press 2018
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6002614/ https://www.ncbi.nlm.nih.gov/pubmed/29861171 http://dx.doi.org/10.1016/j.chom.2018.04.018

Ejemplares similares

Strategies for induction of HIV‐1 envelope‐reactive broadly neutralizing antibodies
por: Williams, Wilton B., et al.
Publicado: (2021)

Progress with induction of HIV broadly neutralizing antibodies in the Duke Consortia for HIV/AIDS Vaccine Development
por: Haynes, Barton F., et al.
Publicado: (2023)

Rapid selection of HIV envelopes that bind to neutralizing antibody B cell lineage members with functional improbable mutations
por: Swanson, Olivia, et al.
Publicado: (2021)

Selection of immunoglobulin elbow region mutations impacts interdomain conformational flexibility in HIV-1 broadly neutralizing antibodies
por: Henderson, Rory, et al.
Publicado: (2019)

HIV envelope V3 region mimic embodies key features of a broadly neutralizing antibody lineage epitope
por: Fera, Daniela, et al.
Publicado: (2018)

Neutralization-guided design of HIV-1 envelope trimers with high affinity for the unmutated common ancestor of CH235 lineage CD4bs broadly neutralizing antibodies
por: LaBranche, Celia C., et al.
Publicado: (2019)

Correction: Neutralization-guided design of HIV-1 envelope trimers with high affinity for the unmutated common ancestor of CH235 lineage CD4bs broadly neutralizing antibodies
por: LaBranche, Celia C., et al.
Publicado: (2019)

Strategies for HIV-1 vaccines that induce broadly neutralizing antibodies
por: Haynes, Barton F., et al.
Publicado: (2022)

Antibody‐virus co‐evolution in HIV infection: paths for HIV vaccine development
por: Bonsignori, Mattia, et al.
Publicado: (2017)

P19-50. Simulation of an MPER peptide samples epitope conformations of two broadly neutralizing antibodies
por: Wiehe, K, et al.
Publicado: (2009)

Envelope Deglycosylation Enhances Antigenicity of HIV-1 gp41 Epitopes for Both Broad Neutralizing Antibodies and Their Unmutated Ancestor Antibodies
por: Ma, Ben-Jiang, et al.
Publicado: (2011)

Identification of autoantigens recognized by the 2F5 and 4E10 broadly neutralizing HIV-1 antibodies
por: Yang, Guang, et al.
Publicado: (2013)

Difficult-to-neutralize global HIV-1 isolates are neutralized by antibodies targeting open envelope conformations
por: Han, Qifeng, et al.
Publicado: (2019)

Inference of the HIV-1 VRC01 Antibody Lineage Unmutated Common Ancestor Reveals Alternative Pathways to Overcome a Key Glycan Barrier
por: Bonsignori, Mattia, et al.
Publicado: (2018)

Maternal Broadly Neutralizing Antibodies Can Select for Neutralization-Resistant, Infant-Transmitted/Founder HIV Variants
por: Martinez, David R., et al.
Publicado: (2020)

Immune System Regulation in the Induction of Broadly Neutralizing HIV-1 Antibodies
por: Kelsoe, Garnett, et al.
Publicado: (2013)

Co-evolution of a broadly neutralizing HIV-1 antibody and founder virus
por: Liao, Hua-Xin, et al.
Publicado: (2013)

Pandemic Preparedness: Developing Vaccines and Therapeutic Antibodies For COVID-19
por: Sempowski, Gregory D., et al.
Publicado: (2020)

mRNA-encoded HIV-1 Env trimer ferritin nanoparticles induce monoclonal antibodies that neutralize heterologous HIV-1 isolates in mice
por: Mu, Zekun, et al.
Publicado: (2022)

A single, improbable B cell receptor mutation confers potent neutralization against cytomegalovirus
por: Jenks, Jennifer A., et al.
Publicado: (2023)

HIV-1 Envelope gp41 Broadly Neutralizing Antibodies: Hurdles for Vaccine Development
por: Verkoczy, Laurent, et al.
Publicado: (2014)

Key mutations stabilize antigen-binding conformation during affinity maturation of a broadly neutralizing influenza antibody lineage
por: Xu, Huafeng, et al.
Publicado: (2015)

Structural analysis of the unmutated ancestor of the HIV-1 envelope V2 region antibody CH58 isolated from an RV144 vaccine efficacy trial vaccinee()
por: Nicely, Nathan I., et al.
Publicado: (2015)

A broadly neutralizing antibody protects against SARS-CoV, pre-emergent bat CoVs, and SARS-CoV-2 variants in mice
por: Martinez, David R., et al.
Publicado: (2021)

Structural and genetic convergence of HIV-1 neutralizing antibodies in vaccinated non-human primates
por: Cai, Fangping, et al.
Publicado: (2021)

Role of framework mutations and antibody flexibility in the evolution of broadly neutralizing antibodies
por: Ovchinnikov, Victor, et al.
Publicado: (2018)

Broad and potent neutralization of HIV-1 by a gp41-specific human antibody
por: Huang, Jinghe, et al.
Publicado: (2012)

HIV-1 envelope glycan modifications that permit neutralization by germline-reverted VRC01-class broadly neutralizing antibodies
por: LaBranche, Celia C., et al.
Publicado: (2018)

Broadly Neutralizing Antibodies Display Potential for Prevention of HIV-1 Infection of Mucosal Tissue Superior to That of Nonneutralizing Antibodies
por: Cheeseman, Hannah M., et al.
Publicado: (2016)

ARMADiLLO: a web server for analyzing antibody mutation probabilities
por: Martin Beem, Joshua S, et al.
Publicado: (2023)

Structural basis for breadth development in the HIV-1 V3-glycan targeting DH270 antibody clonal lineage
por: Henderson, Rory, et al.
Publicado: (2023)

Antibody lineages with evidence of somatic hypermutation persisting for >4 years in a South African subject with broad neutralizing activity
por: Moody, M, et al.
Publicado: (2012)

Correction: HIV-1 envelope glycan modifications that permit neutralization by germline-reverted VRC01-class broadly neutralizing antibodies
por: LaBranche, Celia C., et al.
Publicado: (2019)

Concession to the improbable : an unconventional autobiography /
por: Simpson, George Gaylord, 1902-1984

Broadly Neutralizing Antibodies for HIV Eradication
por: Stephenson, Kathryn E., et al.
Publicado: (2016)

Tackling influenza with broadly neutralizing antibodies
por: Corti, Davide, et al.
Publicado: (2017)

Genetic Signatures in the Envelope Glycoproteins of HIV-1 that Associate with Broadly Neutralizing Antibodies
por: Gnanakaran, S., et al.
Publicado: (2010)

Epitope Specificity of Human Immunodeficiency Virus-1 Antibody Dependent Cellular Cytotoxicity [ADCC] Responses
por: Pollara, Justin, et al.
Publicado: (2013)

Boosting with AIDSVAX B/E Enhances Env Constant Region 1 and 2 Antibody-Dependent Cellular Cytotoxicity Breadth and Potency
por: Easterhoff, David, et al.
Publicado: (2020)

Broad and potent HIV-1 neutralization by a human antibody that binds the gp41-120 interface
por: Huang, Jinghe, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_nefseao8vvajali6pu0n74om00